Recalls / Class II
Class IID-1871-2019
Product
Fexofenadine HCL Tablets USP, 180 mg, 500's BRITE STOCK; Manufactured for: Aurohealth LLC., 2572 Brunswick Pike, Lawrenceville, NJ 08648; Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810.
- Affected lot / code info
- Lot #s:067180011A, 067180012A, Exp 04/21, 06718027B1, Exp 09/21
Why it was recalled
Failed Impurities/Degradation Specifications
Recalling firm
- Firm
- Aurolife Pharma, LLC
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 2400 US Highway 130, N/A, Dayton, New Jersey 08810-1519
Distribution
- Quantity
- 6104 bottles
- Distribution pattern
- Nationwide in the USA
Timeline
- Recall initiated
- 2019-08-23
- FDA classified
- 2019-09-17
- Posted by FDA
- 2019-09-25
- Terminated
- 2022-08-16
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1871-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.